Bilateral vs. unilateral transcranial magnetic stimulation of the primary motor cortex to treat chronic orofacial pain: a pilot study with a randomized controlled design

Bilateral vs. unilateral transcranial magnetic stimulation of the primary motor cortex to treat chronic orofacial pain: a pilot study with a randomized controlled design - BvU-TMS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44200

Enrollment

Registered

2017-11-14

Start date

2018-03-19

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial pain Trigeminal neuropathy

Interventions

Transcranial magnetic stimulation (TMS)

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Untreatable pain in the orofacial region

Exclusion criteria

Exclusion criteria: Intracranial neuromodulation device

Design outcomes

Primary

Measure	Time frame
Primary Objective: Exploring whether bilateral MCS by TMS can provide a greater pain relief as compared to unilateral TMS of the MCS. This will be based on 1) the pain intensity scores before and during the experiment and 2) changes in quality of life during the experiment as measured by the McGill Pain Questionnaire.	—

Secondary

Measure	Time frame
Secondary outcomes of this study will be the experiences of the patients of the experimental period as obtained by interviewing the participants.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)